Grade your knee, name the product, track real function
Stem cell therapy for knee arthritis in Istanbul, Turkey
Our Istanbul protocol for knee osteoarthritis pairs image-guided cell or exosome injections with a documented dose, rehab plan, and clear outcome tracking.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Clinical map
Start with the diagnosis, stage, and treatment context
We define your osteoarthritis grade, alignment, and function goals, then match you to a documented product and a measurable follow-up plan.
Established care comes first
- Exercise and load management: Progressive quadriceps, hip, balance, and aerobic work with weight support and activity modification when needed.
- Pain and support options: Topical or oral NSAIDs, braces, canes, and conventional injections chosen around your individual risk profile.
- Surgical comparison: For advanced disease, we compare our injection protocol honestly against osteotomy or arthroplasty and expected recovery.
- 01
Compartment and grade
Medial, lateral, and patellofemoral involvement and joint-space loss shape your prognosis and your protocol.
- 02
Mechanical context
Alignment, instability, meniscal tears, and prior ligament injury are all mapped before we recommend a plan.
- 03
Inflammatory and referred pain
Effusion, crystal disease, hip pain, or lumbar radiculopathy get their own workup so we treat the right source.
Direct answer
What the current evidence says
Randomized trials show real symptom improvement from culture-expanded MSC injections in knee osteoarthritis, and that's the foundation of our knee program: a graded diagnosis, a named and lab-tested product, an image-guided injection, and a rehabilitation plan that maximizes your result. We're straightforward that no injection guarantees cartilage regrowth or a replacement-free future — what we deliver is the best-documented protocol available, with your knee grade, alignment, and goals driving every decision. Request your free medical evaluation to see what your knee qualifies for.
Evidence position
What is known, what is investigational, and what is not demonstrated
Image-guided knee protocol, matched to your grade
Exercise, strengthening, weight support, and bracing remain core parts of every knee plan we build — the injection supports these, it doesn't replace them.
Image-guided, every time
We tell you exactly which product you're getting — bone marrow concentrate, adipose-derived cells, culture-expanded MSCs, PRP, or exosomes are not interchangeable.
We don't extend knee evidence to IV therapy
Pain improvement is a real outcome we track, but it's not the same as cartilage regeneration, and we won't claim otherwise.
Product and route
A mechanism is not a clinical outcome
- 01
Image-guided, every time
Your knee injection is planned with imaging guidance, sterile technique, a documented dose, and product release data.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
We don't extend knee evidence to IV therapy
Intra-articular research supports a knee injection, not an intravenous product for isolated knee osteoarthritis — we're clear about that boundary.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 Autologous adipose-derived MSC phase 3 trial
Open source- Product
- Culture-expanded autologous adipose-derived MSCs
- Route
- Single intra-articular knee injection
- Design
- Randomized, double-blind, placebo-controlled multicenter phase 3 trial
- Finding
- In patients with Kellgren-Lawrence grade 3 knee osteoarthritis, the study reported better VAS pain and WOMAC changes than placebo at six months, with no significant difference in MRI cartilage defects.
- Limitation
- Six-month results from one culture-expanded product do not establish durability, disease modification, a class effect, or equivalence to other preparations.

Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
WOMAC or KOOS
- 02
Timed walking, stairs, sit-to-stand, and your personal activity goal
- 03
Analgesic use
- 04
Effusion, range of motion, and how you're recovering
- 05
Arthroplasty decision and durability over time
Specialist review
What a complete Istanbul review needs
Our Istanbul protocol for knee osteoarthritis pairs image-guided cell or exosome injections with a documented dose, rehab plan, and clear outcome tracking.
Records and baseline
- Weight-bearing knee radiographs and Kellgren-Lawrence grade
- MRI when meniscus, ligament, or another lesion is suspected
- Alignment, stability, range, strength, effusion, and gait
- Prior exercise therapy, medicines, injections, and surgery
- The exact product, viable cell count, dose, and guidance method for your case
Safety and planning checks
- A locked knee, acute hot swollen joint, fracture, or suspected infection gets prompt conventional care first.
- Your Istanbul quote separates the injectate cost from imaging, procedure, rehabilitation, and follow-up so nothing is hidden.
- We set one or two patient-important activity goals with you and a follow-up schedule before treatment begins.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- A locked knee, acute hot swollen joint, fracture, or suspected infection gets prompt conventional care first.
- Your Istanbul quote separates the injectate cost from imaging, procedure, rehabilitation, and follow-up so nothing is hidden.
- We set one or two patient-important activity goals with you and a follow-up schedule before treatment begins.
Questions the plan must answer
- 01
Image-guided, every time: Your knee injection is planned with imaging guidance, sterile technique, a documented dose, and product release data.
- 02
We don't extend knee evidence to IV therapy: Intra-articular research supports a knee injection, not an intravenous product for isolated knee osteoarthritis — we're clear about that boundary.
Primary reading
Guidelines, trials, and regulatory context
- Autologous adipose-derived MSC knee phase 3 trialAmerican Journal of Sports Medicine · primary study
- Management of osteoarthritis of the knee guidelineAmerican Academy of Orthopaedic Surgeons · guideline
- Osteoarthritis clinical guidelineAmerican College of Rheumatology and Arthritis Foundation · guideline
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.
